ProShare Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3M | Buy |
833,661
+48,255
| +6% | +$3.37M | 0.12% | 162 |
|
|
2025
Q1 | $57.7M | Buy |
785,406
+97,224
| +14% | +$7.15M | 0.13% | 153 |
|
|
2024
Q4 | $45.1M | Buy |
688,182
+107,722
| +19% | +$7.06M | 0.1% | 166 |
|
|
2024
Q3 | $45.2M | Buy |
580,460
+50,882
| +10% | +$3.96M | 0.11% | 154 |
|
|
2024
Q2 | $41.3M | Sell |
529,578
-79,195
| -13% | -$6.18M | 0.11% | 150 |
|
|
2024
Q1 | $41.2M | Buy |
608,773
+121,428
| +25% | +$8.23M | 0.11% | 160 |
|
|
2023
Q4 | $32.8M | Sell |
487,345
-89,724
| -16% | -$6.04M | 0.1% | 194 |
|
|
2023
Q3 | $39.1M | Buy |
577,069
+78,752
| +16% | +$5.33M | 0.12% | 155 |
|
|
2023
Q2 | $35.7M | Sell |
498,317
-45,681
| -8% | -$3.27M | 0.1% | 173 |
|
|
2023
Q1 | $37.8M | Buy |
543,998
+32,550
| +6% | +$2.26M | 0.12% | 161 |
|
|
2022
Q4 | $34.7M | Sell |
511,448
-58,798
| -10% | -$3.99M | 0.12% | 171 |
|
|
2022
Q3 | $31.3M | Sell |
570,246
-95,159
| -14% | -$5.22M | 0.12% | 147 |
|
|
2022
Q2 | $44M | Sell |
665,405
-305,936
| -31% | -$20.2M | 0.15% | 135 |
|
|
2022
Q1 | $64.4M | Buy |
971,341
+885,947
| +1,037% | +$58.8M | 0.14% | 151 |
|
|
2021
Q4 | $4.97M | Buy |
85,394
+18,672
| +28% | +$1.09M | 0.01% | 569 |
|
|
2021
Q3 | $4.01M | Buy |
66,722
+2,630
| +4% | +$158K | 0.01% | 551 |
|
|
2021
Q2 | $3.84M | Buy |
64,092
+503
| +0.8% | +$30.1K | 0.01% | 552 |
|
|
2021
Q1 | $3.16M | Sell |
63,589
-11,896
| -16% | -$592K | 0.01% | 563 |
|
|
2020
Q4 | $3.77M | Buy |
+75,485
| New | +$3.77M | 0.01% | 489 |
|